FDA adcomm reviews safety signals from pediatric RSV trialsnews2024-12-12T20:56:22+00:00December 12th, 2024|Endpoints News|
‘Serious liver injury’ cases on Ocaliva lead FDA to call for monitoringnews2024-12-12T20:20:12+00:00December 12th, 2024|Endpoints News|
RFK Jr. lobbied against vaccine EUAs. At HHS, he could undo themnews2024-12-11T20:09:11+00:00December 11th, 2024|Endpoints News|
Drugs are approved and available faster in US than most of EU, data shownews2024-12-11T18:30:47+00:00December 11th, 2024|Endpoints News|
The Endpoints 100 Survey: Biotech industry braces for Trump 2.0news2024-12-11T12:00:55+00:00December 11th, 2024|Endpoints News|
UniQure stock doubles after FDA meeting on Huntington’s diseasenews2024-12-10T19:39:13+00:00December 10th, 2024|Endpoints News|
Agios’ stock drops after disclosing new liver-related safety warning in filing to FDAnews2024-12-09T19:03:22+00:00December 9th, 2024|Endpoints News|
Merus receives FDA accelerated approval to treat NRG1+ cancersnews2024-12-05T20:51:50+00:00December 5th, 2024|Endpoints News|
USPTO withdraws proposed patent rule criticized by pharma industrynews2024-12-05T20:24:41+00:00December 5th, 2024|Endpoints News|
FDA spells out expedited withdrawal process for accelerated approvalsnews2024-12-05T20:03:05+00:00December 5th, 2024|Endpoints News|
